Mount Sinai and PinkStar Enter Collaboration to Advance Breast MRI AI Technology

Collaboration to strengthen clinical data foundation behind PinkStar, advancing breast MRI AI technology for enhanced interpretation and early cancer detection

RAMAT GAN, ISRAEL, August 11, 2026 /EINPresswire.com/ -- PinkStar, a medical AI company developing decision support technology for breast MRI, today announced the signing of a Data and Collaboration Agreement with Mount Sinai Health System to enable data sharing to power and train PinkStar’s AI technology for breast MRI interpretation, which was developed at Sheba Medical Center.

Breast MRI is the most sensitive imaging modality for detecting breast cancer. While its use is expanding rapidly, driven by evolving screening recommendations and increasing breast density awareness, the imaging is among the most complex and time-intensive to interpret. As a result, while AI-based interpretation tools have become widely available for mammography and ultrasound, breast MRI has been left largely without comparable decision support.

PinkStar was built to close that gap. Developed at the Sheba Medical Center through its ARC innovation arm, the technology will assist radiologists at the point of MRI reading, providing AI-driven characterization of suspicious findings to support the detection of early-stage lesions, improve interpretation efficiency and consistency across readers, and reduce unnecessary biopsies.

The agreement marks the company's first clinical collaboration with a leading U.S. academic medical institution, with Mount Sinai making a long-term commitment to advancing the technology. The collaboration will be led by Dr. Laurie Margolies, Professor of Radiology at the Icahn School of Medicine at Mount Sinai and Vice-Chair for Breast Imaging, and Dr. Elisa Port, Chief of Breast Surgery at Mount Sinai Health System, through the Tisch Cancer Center, an NCI-designated comprehensive cancer center, and its Center of Excellence for Breast Cancer.

“PinkStar's mission is to help detect breast cancer earlier by giving radiologists AI-based decision support for breast MRI,” said Sivan Sadan, Co-Founder and CEO of PinkStar. “This collaboration will enable us to train and validate our technology on high-quality, real-world clinical data, under the guidance of Dr. Laurie Margolies, Dr. Elisa Port, and their teams at Mount Sinai. Together, we aim to empower more objective clinical decision-making and make breast MRI a clinically impactful and economically sustainable solution.”

For Mount Sinai, the collaboration reflects a longstanding commitment to advancing the science of early detection and bringing emerging technologies into clinical practice. By contributing its clinical expertise, scientific knowledge and data to the development of PinkStar's technology, Mount Sinai aims to help shape a new generation of decision-support tools, built and validated against the complexity of real-world cases, that can ultimately support radiologists' reads and earlier, more accurate diagnoses for patients.

“At Mount Sinai, we believe meaningful innovation happens when healthcare institutions and technology companies work together to address real-world healthcare needs,” said Dr. Nicholas Gavin, Chief Innovation Officer at Mount Sinai Health System. “Earlier detection remains one of the most important factors in improving outcomes for breast cancer patients, and this collaboration combines Mount Sinai’s knowledge with PinkStar’s technology and scientific foundation to address a critical need in breast cancer detection. As breast MRI becomes more widely used, AI has the potential to help identify cancers earlier and improve patient care.”

“Breast imaging radiologists across the Mount Sinai Health System use AI every day to help deliver accurate, timely interpretations of mammography and breast ultrasound,” said Dr. Laurie Margolies, Professor of Radiology at the Icahn School of Medicine at Mount Sinai and Vice-Chair for Breast Imaging. “Breast MRI, the most advanced imaging tool for many patients at high risk for or diagnosed with breast cancer, remains the only major breast imaging modality without an FDA-cleared AI solution to support interpretation and clinical decision-making. This collaboration with PinkStar will help close this gap by enhancing diagnostic confidence and ultimately improving care for the patients who depend on breast MRI.”

“PinkStar is poised to bring life-saving innovation to women worldwide and this agreement with Mount Sinai is a meaningful step towards actualizing that vision,” said Dan Shwarzman, CEO of embARC Ventures, a healthtech venture fund established in partnership with ARC at Sheba Medical Center. “embARC was created to help early-stage healthtech companies navigate their most critical growth stages, and we are committed to supporting PinkStar's journey as part of that mission. This is just the beginning of bringing better, more personalized and rigorous care to the world.”

About PinkStar
PinkStar is a medical AI company developing decision-support technology for breast MRI. Founded on technology developed at Sheba Medical Center through its ARC innovation engine, the company is focused on advancing more objective, accurate, and scalable breast MRI interpretation to support radiologists in the early detection of breast cancer and improve patient outcomes.

The company was co-founded by Sivan Sadan, Dr. Debbie Anaby, Head of the Breast Imaging Lab at Sheba Medical Center, and Prof. Miri Sklair-Levy, renowned breast imaging expert and Head of the Breast Imaging Unit at Sheba’s Meirav Breast Cancer Center. Together, the founders combine deep expertise in healthcare, medical imaging, entrepreneurship, and artificial intelligence to address one of the most important challenges in women's health.

PinkStar's mission is to help improve outcomes for women by enabling earlier cancer detection, supporting more objective clinical decision-making, and making breast MRI a scalable and financially viable solution for healthcare systems worldwide.

For more information, visit http://www.pinkstar.life

About Sheba Medical Center
The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research, and healthcare transformation. Sheba’s City of Health unites specialty hospitals, research and simulation centers, a virtual hospital, and its innovation arm ARC (Accelerate, Redesign, Collaborate), which connects entrepreneurs and clinicians to advance the development and implementation of new AI and tech solutions in healthcare, and accelerates the adoption of innovation both within the hospital and in health systems worldwide. Sheba is one of the top-ten hospitals in the world, having been ranked a World’s Best Hospital by Newsweek for the last eight consecutive years (2019–2026). For more information, visit: https://sheba-global.com or https://arcinnovation.org

About Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with over 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time-discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s^® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's^® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report^® “Best Hospitals” Honor Roll for 2025-2026.

For more information, visit https://www.mountsinai.org

Aviva Sapir
Number 10 Strategies
email us here